{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-27",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "third_party_flag": "N",
      "city": "Carlsbad",
      "advisory_committee_description": "Immunology",
      "address_1": "2075 Corte Del Nogal",
      "address_2": "Suite J",
      "statement_or_summary": "Summary",
      "product_code": "OWM",
      "openfda": {
        "registration_number": [
          "3005360469"
        ],
        "fei_number": [
          "3005670738"
        ],
        "device_name": "Prostate-Specific Antigen (Psa) For Prognostic, Recurrence Risk Assessment Of Prostate Cancers",
        "medical_specialty_description": "Immunology",
        "regulation_number": "866.6040",
        "device_class": "2"
      },
      "zip_code": "92011",
      "applicant": "Iris Molecular Diagnostics",
      "decision_date": "2011-09-20",
      "decision_code": "SESE",
      "country_code": "US",
      "device_name": "NUCLEIC ACID DETECTION IMMUNOASSAY (NADIA) PSA ASSAY",
      "advisory_committee": "IM",
      "contact": "ROBERT  KLEM",
      "expedited_review_flag": "",
      "k_number": "K101185",
      "state": "CA",
      "date_received": "2010-04-28",
      "review_advisory_committee": "IM",
      "postal_code": "92011",
      "decision_description": "Substantially Equivalent",
      "clearance_type": "Traditional"
    }
  ]
}